カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の網膜血管炎治療市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Retinal Vasculitis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19602）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19602
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の網膜血管炎治療市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

網膜血管炎治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の網膜血管炎治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

網膜血管炎治療市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫抑制剤、コルチコステロイド剤

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の網膜血管炎治療市場の主要な市場プレーヤーは以下のとおりです。
・Celgene Corporation、Merck & Co、Novartis AG、F. Hoffmann-La Roche、GlaxoSmithKline plc、Bristol-Myers Squibb Company、RNL BIO Co., Ltd.、Teijin Pharma Limited、Anthera Pharmaceuticals、Human Genome Sciences, Inc.、Novo Nordisk A/S、Eli Lilly and Company

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、網膜血管炎治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な網膜血管炎治療メーカーの企業概要、2019年～2022年までの網膜血管炎治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な網膜血管炎治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別網膜血管炎治療の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの網膜血管炎治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での網膜血管炎治療市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および網膜血管炎治療の産業チェーンを掲載しています。
・第13、14、15章では、網膜血管炎治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 網膜血管炎治療の概要
- 種類別分析（2017年vs2021年vs2028年）：免疫抑制剤、コルチコステロイド剤
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の網膜血管炎治療市場規模・予測
- 世界の網膜血管炎治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Celgene Corporation、Merck & Co、Novartis AG、F. Hoffmann-La Roche、GlaxoSmithKline plc、Bristol-Myers Squibb Company、RNL BIO Co., Ltd.、Teijin Pharma Limited、Anthera Pharmaceuticals、Human Genome Sciences, Inc.、Novo Nordisk A/S、Eli Lilly and Company
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫抑制剤、コルチコステロイド剤
・用途別分析2017年-2028年：病院、診療所、その他
・網膜血管炎治療の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・網膜血管炎治療のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・網膜血管炎治療のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・網膜血管炎治療の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・網膜血管炎治療の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Retinal Vasculitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Retinal Vasculitis Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Retinal Vasculitis Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunosuppressive Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Retinal Vasculitis Treatment include Celgene Corporation, Merck & Co, Novartis AG, F. Hoffmann-La Roche, and GlaxoSmithKline plc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Retinal Vasculitis Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunosuppressive Drug
corticosteroid Drug
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Retinal Vasculitis Treatment market are listed below:
Celgene Corporation
Merck & Co
Novartis AG
F. Hoffmann-La Roche
GlaxoSmithKline plc
Bristol-Myers Squibb Company
RNL BIO Co., Ltd.
Teijin Pharma Limited
Anthera Pharmaceuticals
Human Genome Sciences, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Retinal Vasculitis Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Retinal Vasculitis Treatment, with price, sales, revenue and global market share of Retinal Vasculitis Treatment from 2019 to 2022.
Chapter 3, the Retinal Vasculitis Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Retinal Vasculitis Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Retinal Vasculitis Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Retinal Vasculitis Treatment.
Chapter 13, 14, and 15, to describe Retinal Vasculitis Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Retinal Vasculitis Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Retinal Vasculitis Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immunosuppressive Drug
1.2.3 corticosteroid Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Retinal Vasculitis Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Retinal Vasculitis Treatment Market Size & Forecast
1.4.1 Global Retinal Vasculitis Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Retinal Vasculitis Treatment Sales in Volume (2017-2028)
1.4.3 Global Retinal Vasculitis Treatment Price (2017-2028)
1.5 Global Retinal Vasculitis Treatment Production Capacity Analysis
1.5.1 Global Retinal Vasculitis Treatment Total Production Capacity (2017-2028)
1.5.2 Global Retinal Vasculitis Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Vasculitis Treatment Market Drivers
1.6.2 Retinal Vasculitis Treatment Market Restraints
1.6.3 Retinal Vasculitis Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Celgene Corporation
2.1.1 Celgene Corporation Details
2.1.2 Celgene Corporation Major Business
2.1.3 Celgene Corporation Retinal Vasculitis Treatment Product and Services
2.1.4 Celgene Corporation Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co Retinal Vasculitis Treatment Product and Services
2.2.4 Merck & Co Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Retinal Vasculitis Treatment Product and Services
2.3.4 Novartis AG Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Retinal Vasculitis Treatment Product and Services
2.4.4 F. Hoffmann-La Roche Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business
2.5.3 GlaxoSmithKline plc Retinal Vasculitis Treatment Product and Services
2.5.4 GlaxoSmithKline plc Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company Retinal Vasculitis Treatment Product and Services
2.6.4 Bristol-Myers Squibb Company Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 RNL BIO Co., Ltd.
2.7.1 RNL BIO Co., Ltd. Details
2.7.2 RNL BIO Co., Ltd. Major Business
2.7.3 RNL BIO Co., Ltd. Retinal Vasculitis Treatment Product and Services
2.7.4 RNL BIO Co., Ltd. Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teijin Pharma Limited
2.8.1 Teijin Pharma Limited Details
2.8.2 Teijin Pharma Limited Major Business
2.8.3 Teijin Pharma Limited Retinal Vasculitis Treatment Product and Services
2.8.4 Teijin Pharma Limited Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Anthera Pharmaceuticals
2.9.1 Anthera Pharmaceuticals Details
2.9.2 Anthera Pharmaceuticals Major Business
2.9.3 Anthera Pharmaceuticals Retinal Vasculitis Treatment Product and Services
2.9.4 Anthera Pharmaceuticals Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Human Genome Sciences, Inc.
2.10.1 Human Genome Sciences, Inc. Details
2.10.2 Human Genome Sciences, Inc. Major Business
2.10.3 Human Genome Sciences, Inc. Retinal Vasculitis Treatment Product and Services
2.10.4 Human Genome Sciences, Inc. Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novo Nordisk A/S
2.11.1 Novo Nordisk A/S Details
2.11.2 Novo Nordisk A/S Major Business
2.11.3 Novo Nordisk A/S Retinal Vasculitis Treatment Product and Services
2.11.4 Novo Nordisk A/S Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Retinal Vasculitis Treatment Product and Services
2.12.4 Eli Lilly and Company Retinal Vasculitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Retinal Vasculitis Treatment Breakdown Data by Manufacturer
3.1 Global Retinal Vasculitis Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Retinal Vasculitis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Retinal Vasculitis Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Retinal Vasculitis Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Retinal Vasculitis Treatment Manufacturer Market Share in 2021
3.5 Global Retinal Vasculitis Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Retinal Vasculitis Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Retinal Vasculitis Treatment Market Size by Region
4.1.1 Global Retinal Vasculitis Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Retinal Vasculitis Treatment Revenue by Region (2017-2028)
4.2 North America Retinal Vasculitis Treatment Revenue (2017-2028)
4.3 Europe Retinal Vasculitis Treatment Revenue (2017-2028)
4.4 Asia-Pacific Retinal Vasculitis Treatment Revenue (2017-2028)
4.5 South America Retinal Vasculitis Treatment Revenue (2017-2028)
4.6 Middle East and Africa Retinal Vasculitis Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Retinal Vasculitis Treatment Sales in Volume by Type (2017-2028)
5.2 Global Retinal Vasculitis Treatment Revenue by Type (2017-2028)
5.3 Global Retinal Vasculitis Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Retinal Vasculitis Treatment Sales in Volume by Application (2017-2028)
6.2 Global Retinal Vasculitis Treatment Revenue by Application (2017-2028)
6.3 Global Retinal Vasculitis Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Retinal Vasculitis Treatment Sales by Type (2017-2028)
7.2 North America Retinal Vasculitis Treatment Sales by Application (2017-2028)
7.3 North America Retinal Vasculitis Treatment Market Size by Country
7.3.1 North America Retinal Vasculitis Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Retinal Vasculitis Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Retinal Vasculitis Treatment Sales by Type (2017-2028)
8.2 Europe Retinal Vasculitis Treatment Sales by Application (2017-2028)
8.3 Europe Retinal Vasculitis Treatment Market Size by Country
8.3.1 Europe Retinal Vasculitis Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Retinal Vasculitis Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Retinal Vasculitis Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Retinal Vasculitis Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Retinal Vasculitis Treatment Market Size by Region
9.3.1 Asia-Pacific Retinal Vasculitis Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Retinal Vasculitis Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Retinal Vasculitis Treatment Sales by Type (2017-2028)
10.2 South America Retinal Vasculitis Treatment Sales by Application (2017-2028)
10.3 South America Retinal Vasculitis Treatment Market Size by Country
10.3.1 South America Retinal Vasculitis Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Retinal Vasculitis Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Retinal Vasculitis Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Retinal Vasculitis Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Retinal Vasculitis Treatment Market Size by Country
11.3.1 Middle East & Africa Retinal Vasculitis Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Retinal Vasculitis Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Retinal Vasculitis Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Retinal Vasculitis Treatment
12.3 Retinal Vasculitis Treatment Production Process
12.4 Retinal Vasculitis Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Retinal Vasculitis Treatment Typical Distributors
13.3 Retinal Vasculitis Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Retinal Vasculitis Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Retinal Vasculitis Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Corporation Major Business
Table 5. Celgene Corporation Retinal Vasculitis Treatment Product and Services
Table 6. Celgene Corporation Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co Major Business
Table 9. Merck & Co Retinal Vasculitis Treatment Product and Services
Table 10. Merck & Co Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 12. Novartis AG Major Business
Table 13. Novartis AG Retinal Vasculitis Treatment Product and Services
Table 14. Novartis AG Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Major Business
Table 17. F. Hoffmann-La Roche Retinal Vasculitis Treatment Product and Services
Table 18. F. Hoffmann-La Roche Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline plc Major Business
Table 21. GlaxoSmithKline plc Retinal Vasculitis Treatment Product and Services
Table 22. GlaxoSmithKline plc Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Company Major Business
Table 25. Bristol-Myers Squibb Company Retinal Vasculitis Treatment Product and Services
Table 26. Bristol-Myers Squibb Company Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. RNL BIO Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. RNL BIO Co., Ltd. Major Business
Table 29. RNL BIO Co., Ltd. Retinal Vasculitis Treatment Product and Services
Table 30. RNL BIO Co., Ltd. Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teijin Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 32. Teijin Pharma Limited Major Business
Table 33. Teijin Pharma Limited Retinal Vasculitis Treatment Product and Services
Table 34. Teijin Pharma Limited Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Anthera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Anthera Pharmaceuticals Major Business
Table 37. Anthera Pharmaceuticals Retinal Vasculitis Treatment Product and Services
Table 38. Anthera Pharmaceuticals Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Human Genome Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Human Genome Sciences, Inc. Major Business
Table 41. Human Genome Sciences, Inc. Retinal Vasculitis Treatment Product and Services
Table 42. Human Genome Sciences, Inc. Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 44. Novo Nordisk A/S Major Business
Table 45. Novo Nordisk A/S Retinal Vasculitis Treatment Product and Services
Table 46. Novo Nordisk A/S Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 48. Eli Lilly and Company Major Business
Table 49. Eli Lilly and Company Retinal Vasculitis Treatment Product and Services
Table 50. Eli Lilly and Company Retinal Vasculitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Retinal Vasculitis Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Retinal Vasculitis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Retinal Vasculitis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Retinal Vasculitis Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Retinal Vasculitis Treatment Production Site of Key Manufacturer
Table 56. Retinal Vasculitis Treatment New Entrant and Capacity Expansion Plans
Table 57. Retinal Vasculitis Treatment Mergers & Acquisitions in the Past Five Years
Table 58. Global Retinal Vasculitis Treatment Sales by Region (2017-2022) & (K Units)
Table 59. Global Retinal Vasculitis Treatment Sales by Region (2023-2028) & (K Units)
Table 60. Global Retinal Vasculitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Retinal Vasculitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 63. Global Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 64. Global Retinal Vasculitis Treatment Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Retinal Vasculitis Treatment Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Retinal Vasculitis Treatment Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Retinal Vasculitis Treatment Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 69. Global Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 70. Global Retinal Vasculitis Treatment Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Retinal Vasculitis Treatment Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Retinal Vasculitis Treatment Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Retinal Vasculitis Treatment Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Retinal Vasculitis Treatment Sales by Country (2017-2022) & (K Units)
Table 75. North America Retinal Vasculitis Treatment Sales by Country (2023-2028) & (K Units)
Table 76. North America Retinal Vasculitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Retinal Vasculitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 79. North America Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 80. North America Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 81. North America Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 82. Europe Retinal Vasculitis Treatment Sales by Country (2017-2022) & (K Units)
Table 83. Europe Retinal Vasculitis Treatment Sales by Country (2023-2028) & (K Units)
Table 84. Europe Retinal Vasculitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Retinal Vasculitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 87. Europe Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 88. Europe Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 89. Europe Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Retinal Vasculitis Treatment Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Retinal Vasculitis Treatment Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Retinal Vasculitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Retinal Vasculitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 98. South America Retinal Vasculitis Treatment Sales by Country (2017-2022) & (K Units)
Table 99. South America Retinal Vasculitis Treatment Sales by Country (2023-2028) & (K Units)
Table 100. South America Retinal Vasculitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Retinal Vasculitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 103. South America Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 104. South America Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 105. South America Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Retinal Vasculitis Treatment Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Retinal Vasculitis Treatment Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Retinal Vasculitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Retinal Vasculitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Retinal Vasculitis Treatment Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Retinal Vasculitis Treatment Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Retinal Vasculitis Treatment Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Retinal Vasculitis Treatment Sales by Application (2023-2028) & (K Units)
Table 114. Retinal Vasculitis Treatment Raw Material
Table 115. Key Manufacturers of Retinal Vasculitis Treatment Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Retinal Vasculitis Treatment Typical Distributors
Table 119. Retinal Vasculitis Treatment Typical Customers
List of Figures
Figure 1. Retinal Vasculitis Treatment Picture
Figure 2. Global Retinal Vasculitis Treatment Revenue Market Share by Type in 2021
Figure 3. Immunosuppressive Drug
Figure 4. corticosteroid Drug
Figure 5. Global Retinal Vasculitis Treatment Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Retinal Vasculitis Treatment Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Retinal Vasculitis Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Retinal Vasculitis Treatment Sales (2017-2028) & (K Units)
Figure 12. Global Retinal Vasculitis Treatment Price (2017-2028) & (US$/Unit)
Figure 13. Global Retinal Vasculitis Treatment Production Capacity (2017-2028) & (K Units)
Figure 14. Global Retinal Vasculitis Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Retinal Vasculitis Treatment Market Drivers
Figure 16. Retinal Vasculitis Treatment Market Restraints
Figure 17. Retinal Vasculitis Treatment Market Trends
Figure 18. Global Retinal Vasculitis Treatment Sales Market Share by Manufacturer in 2021
Figure 19. Global Retinal Vasculitis Treatment Revenue Market Share by Manufacturer in 2021
Figure 20. Retinal Vasculitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Retinal Vasculitis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Retinal Vasculitis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Retinal Vasculitis Treatment Sales Market Share by Region (2017-2028)
Figure 24. Global Retinal Vasculitis Treatment Revenue Market Share by Region (2017-2028)
Figure 25. North America Retinal Vasculitis Treatment Revenue (2017-2028) & (USD Million)
Figure 26. Europe Retinal Vasculitis Treatment Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Retinal Vasculitis Treatment Revenue (2017-2028) & (USD Million)
Figure 28. South America Retinal Vasculitis Treatment Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Retinal Vasculitis Treatment Revenue (2017-2028) & (USD Million)
Figure 30. Global Retinal Vasculitis Treatment Sales Market Share by Type (2017-2028)
Figure 31. Global Retinal Vasculitis Treatment Revenue Market Share by Type (2017-2028)
Figure 32. Global Retinal Vasculitis Treatment Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Retinal Vasculitis Treatment Revenue Market Share by Application (2017-2028)
Figure 35. Global Retinal Vasculitis Treatment Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Retinal Vasculitis Treatment Sales Market Share by Type (2017-2028)
Figure 37. North America Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Retinal Vasculitis Treatment Sales Market Share by Country (2017-2028)
Figure 39. North America Retinal Vasculitis Treatment Revenue Market Share by Country (2017-2028)
Figure 40. United States Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Retinal Vasculitis Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 45. Europe Retinal Vasculitis Treatment Sales Market Share by Country (2017-2028)
Figure 46. Europe Retinal Vasculitis Treatment Revenue Market Share by Country (2017-2028)
Figure 47. Germany Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Retinal Vasculitis Treatment Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Retinal Vasculitis Treatment Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Retinal Vasculitis Treatment Revenue Market Share by Region (2017-2028)
Figure 56. China Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Retinal Vasculitis Treatment Sales Market Share by Type (2017-2028)
Figure 63. South America Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 64. South America Retinal Vasculitis Treatment Sales Market Share by Country (2017-2028)
Figure 65. South America Retinal Vasculitis Treatment Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Retinal Vasculitis Treatment Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Retinal Vasculitis Treatment Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Retinal Vasculitis Treatment Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Retinal Vasculitis Treatment Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Retinal Vasculitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Retinal Vasculitis Treatment in 2021
Figure 77. Manufacturing Process Analysis of Retinal Vasculitis Treatment
Figure 78. Retinal Vasculitis Treatment Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 遺伝性網膜疾患治療剤のグローバル市場展望 2023年-2029年：遺伝子治療、人工網膜、神経保護剤
  • 世界の網膜カメラ市場2022年：市場規模予測（～2028年）
  • 超広視野眼底カメラの世界市場2023年：モバイル眼底カメラ、固定眼底カメラ
  • 網膜のグローバル市場展望 2023年-2029年：純度98%、純度99%
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19602 )"世界の網膜血管炎治療市場2022年：市場規模予測（～2028年）" (英文：Global Retinal Vasculitis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。